SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-014115
Filing Date
2022-05-17
Accepted
2022-05-17 09:30:19
Documents
15
Period of Report
2022-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42094
2 ex99-1.htm EX-99.1 39440
3 ex99-1_001.jpg GRAPHIC 3091
4 ex99-1_002.jpg GRAPHIC 2235
  Complete submission text file 0001493152-22-014115.txt   271479

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogen-20220517.xsd EX-101.SCH 3036
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogen-20220517_lab.xml EX-101.LAB 34476
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogen-20220517_pre.xml EX-101.PRE 22597
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3583
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 22932539
SIC: 2834 Pharmaceutical Preparations